Browse by Day Archive

Salmonella outbreak in cucumbers hits 25 states and DC

06/06/2024 10:04pm
The Centers for Disease Control and Prevention says 162 people from 25 states and Washington became sick from salmonella that officials believe might be linked to cucumbers.

'Ransom: Position of Trust': Hilton’s Story

06/06/2024 8:35pm
Late on the night of Saturday, September 16th, 1995 four days after kidnapping McKay, Hilton Crawford drew Sheriff Guy

Trump, in first post-trial rally, demands appeals courts reverse felony conviction

06/06/2024 7:43pm
Donald Trump has returned to the campaign trail with a trip to Arizona, his first appearance in a battleground state since he was convicted in a hush money scandal.

Walmart starts bonus program for hourly workers

06/06/2024 6:17pm
New York (cnn) — Walmart, America’s largest private-sector employer, is starting a bonus program for its hourly

European Union cuts interest rate. Federal Reserve could follow

06/06/2024 5:21pm
For the first time in almost five years, the European Central Bank cut its key interest rate by a quarter percentage point on Thursday, moving from 4.0% to 3.75% in a widely anticipated decision by the bank's governing body.

SpaceX marks first successful Starship test behind Boeing's debut crewed mission

06/06/2024 5:12pm
SpaceX completed a successful test flight of its massive Starship spacecraft on the fourth attempt following a trio of previous flights that ended in fiery destruction.

A new 'Hunger Games' book — and movie — is coming

06/06/2024 4:33pm
Suzanne Collins is returning to the ravaged, post-apocalyptic land of Panem for a new "The Hunger Games" novel. Scholastic announced Thursday that "Sunrise on the Reaping" will be published March 18, 2025.

As AI booms, Microsoft’s deal with a startup comes under federal investigation

06/06/2024 3:39pm
Washington (cnn) — The Federal Trade Commission is investigating a recent Microsoft deal with artificial intelligence

FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug

06/06/2024 3:28pm
An FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease.